siRNA therapy lowers triglycerides in people along with uncommon ailment

.ANALYSIS FEATURE.19 September 2024.

Plozasiran decreased triglyceride levels through 80% and decreased the threat of pancreatitis in patients with chronic chylomicronemia, along with or even without a hereditary prognosis.